Using cutting-edge biomaterials and ingenious manufacturing methods, Deepak’s lab produces co-axial extruded, multilayer, growth factor depot-functionalized cellularized blood vessels. The sustained-release growth factor depots direct to differentiate and maturation of the stem cells in situ without additional intervention.

Join us for our ‘Immunoassay Application Week’ featuring daily FREE online workshops to help you optimize your assay performance. Take a deep dive into the science behind the workflows to better understand popular assays including Flow Cytometry, ELISA, Western Blot, Chromatin Immunoprecipitation (ChIP), and Immunofluorescence.

Ex vivo drug response profiling has emerged as a promising tool for studying genotype–drug response associations, offering the potential for precision medicine, especially in cancer treatment. In this webinar, Peter-Martin Bruch will discuss the findings from the SMARTrial (NCT03488641), a prospective non-interventional trial that investigated the feasibility of ex vivo drug response profiling for guiding treatment decisions in hematologic malignancies. With a 91% of study results delivered within seven days, the trial highlighted the feasibility of this approach. More importantly, it showed in vivo therapy response beyond known genetic risk factors, demonstrating how functional profiling can enhance risk stratification and treatment personalization beyond traditional genetic markers.